Literature DB >> 14622213

Characterization of the rat A2A adenosine receptor gene: a 4.8-kb promoter-proximal DNA fragment confers selective expression in the central nervous system.

Yi-Chao Lee1, Chen-Li Chien, Chung-Nan Sun, Chuen-Lin Huang, Nai-Kuei Huang, Ming-Chang Chiang, Hsing-Lin Lai, Yow-Sien Lin, Szu-Yi Chou, Chi-Kuang Leo Wang, Ming-Hong Tai, Wen-Lin Liao, Teng-Nan Lin, Fu-Chin Liu, Yijuang Chern.   

Abstract

We isolated and characterized a 4.8-kb 5' flanking region of the rat A2A adenosine receptor (A2A-R) gene in the present study. Promoter activity was observed with this DNA fragment in PC12 cells and C6 cells which contain endogenous A2A-Rs. A fusion fragment consisting of the 4.8-kb promoter-proximal DNA fragment of the A2A-R gene, and the coding region of lacZ was utilized to produce mice harbouring the fusion gene. In three independent founder lines, proteins and transcripts of the transgene were found in many areas of the central nervous system (CNS), but not in three peripheral tissues examined. Double immunohistochemical analyses revealed that the transgene was coexpressed with endogenous A2A-R and proper neuronal markers in the brain. Specifically, the transgene in the striatum was found in the enkephalin-containing GABAergic neurons and in the cholinergic neurons as was found for the endogenous A2A-R. However, a selectively enriched striatal expression of the transgene was not found as was observed for the endogenous A2A-R. Collectively, the 4.8-kb promoter-proximal DNA fragment of the rat A2A-R gene contains important element(s) to direct its expression in the CNS where functional A2A-R are found, but were not sufficient to confer the highly concentrated expression of the striatal A2A-R. Furthermore, expressions of A2A-R and the transgene were found in both neurons and astrocytes, suggesting that adenosine might mediate its function through A2A-R in both cell types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622213     DOI: 10.1046/j.1460-9568.2003.02907.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  15 in total

1.  Enhanced ATP release and CD73-mediated adenosine formation sustain adenosine A2A receptor over-activation in a rat model of Parkinson's disease.

Authors:  Marta Carmo; Francisco Q Gonçalves; Paula M Canas; Jean-Pierre Oses; Francisco D Fernandes; Filipe V Duarte; Carlos M Palmeira; Angelo R Tomé; Paula Agostinho; Geanne M Andrade; Rodrigo A Cunha
Journal:  Br J Pharmacol       Date:  2019-08-01       Impact factor: 8.739

Review 2.  Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.

Authors:  Marie Therese Armentero; Annalisa Pinna; Sergi Ferré; José Luis Lanciego; Christa E Müller; Rafael Franco
Journal:  Pharmacol Ther       Date:  2011-07-23       Impact factor: 12.310

3.  Time-course of protection by the selective A2A receptor antagonist SCH58261 after transient focal cerebral ischemia.

Authors:  Alessia Melani; Ilaria Dettori; Francesca Corti; Lucrezia Cellai; Felicita Pedata
Journal:  Neurol Sci       Date:  2015-03-25       Impact factor: 3.307

Review 4.  Pathophysiological roles for purines: adenosine, caffeine and urate.

Authors:  Micaela Morelli; Anna R Carta; Anil Kachroo; Michael A Schwarzschild
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 5.  Mechanisms of induction of adenosine receptor genes and its functional significance.

Authors:  Cynthia St Hilaire; Shannon H Carroll; Hongjie Chen; Katya Ravid
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

6.  The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.

Authors:  A M Pugliese; C Traini; S Cipriani; M Gianfriddo; T Mello; M G Giovannini; A Galli; F Pedata
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

Review 7.  Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington's and Parkinson's Disease.

Authors:  Talita Glaser; Roberta Andrejew; Ágatha Oliveira-Giacomelli; Deidiane Elisa Ribeiro; Lucas Bonfim Marques; Qing Ye; Wen-Jing Ren; Alexey Semyanov; Peter Illes; Yong Tang; Henning Ulrich
Journal:  Neurosci Bull       Date:  2020-10-07       Impact factor: 5.203

8.  Endogenous expression of adenosine A1, A2 and A3 receptors in rat C6 glioma cells.

Authors:  Carlos Alberto Castillo; José Luís Albasanz; Mercedes Fernández; Mairena Martín
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

9.  The role of ATP and adenosine in the brain under normoxic and ischemic conditions.

Authors:  F Pedata; A Melani; A M Pugliese; E Coppi; S Cipriani; C Traini
Journal:  Purinergic Signal       Date:  2007-10-11       Impact factor: 3.765

10.  Adenosine A(2A) receptor up-regulates retinal wave frequency via starburst amacrine cells in the developing rat retina.

Authors:  Pin-Chien Huang; Yu-Tien Hsiao; Shao-Yen Kao; Ching-Feng Chen; Yu-Chieh Chen; Chung-Wei Chiang; Chien-Fei Lee; Juu-Chin Lu; Yijuang Chern; Chih-Tien Wang
Journal:  PLoS One       Date:  2014-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.